Barbara Weber - Sep 1, 2023 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Director
Signature
/s/ Jack Anders, as Attorney-in-fact for Barbara Weber
Stock symbol
RVMD
Transactions as of
Sep 1, 2023
Transactions value $
-$468,963
Form type
4
Date filed
9/6/2023, 08:03 PM
Previous filing
Jun 12, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $4.32K +3.85K +24.35% $1.12* 19.7K Sep 1, 2023 Direct F1, F2
transaction RVMD Common Stock Options Exercise $52.7K +11.1K +56.64% $4.73* 30.8K Sep 1, 2023 Direct F1, F2
transaction RVMD Common Stock Sale -$526K -15K -48.66% $35.07 15.8K Sep 1, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -3.85K -28.57% $0.00 9.64K Sep 1, 2023 Common Stock 3.85K $1.12 Direct F1
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -11.1K -85.76% $0.00 1.85K Sep 1, 2023 Common Stock 11.1K $4.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022.
F2 Includes 5,200 restricted stock units.
F3 The transaction was executed in multiple trades in prices ranging from $35.00 to $35.24, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.